packageLarotrectinib

larotrectinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Larotrectinib is a protein kinase inhibitor used to treat cancer. It is an approved anticancer medicine authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27081513 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:larotrectinib
ATC codes:L01EX12, L01XE53
DrugBank:DB14723
PubChem CID:46188928
Wikidata:Q27081513
formula:C21H22F2N6O2
molar mass:428.443 g/mol (PubChem CID 46188928)
logP:1.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown